Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 736
Filter
1.
Port J Card Thorac Vasc Surg ; 31(1): 59-62, 2024 May 13.
Article in English | MEDLINE | ID: mdl-38743514

ABSTRACT

INTRODUCTION: Purulent pericarditis secondary to esophago-pericardial fistula is a serious complication that has been previously reported in patients with esophageal cancer treated with radio/chemotherapy and esophageal stenting. However, the presence of esophago-pericardial fistula as the first manifestation of advanced carcinoma of the esophagus is exceedingly infrequent. We report the case of a 61-year-old male who presented with sepsis, cardiac tamponade and septic shock who was found to have an esophago-pericardial fistula secondary to squamous carcinoma of the esophagus. Emergency pericardiocentesis was performed with subsequent hemodynamic improvement. The drained pericardial fluid was purulent in nature and cultures were positive for Streptococcus anginosus. A CT scan followed by upper gastrointestinal endoscopy with tissue biopsy confirmed the diagnosis of squamous cell carcinoma of the esophagus. A self-expanding covered stent was endoscopically placed to exclude the fistula and restore the esophageal lumen. In this report, we discuss some aspects related to the diagnosis and management of this serious clinical entity.


Subject(s)
Carcinoma, Squamous Cell , Esophageal Fistula , Esophageal Neoplasms , Pericarditis , Humans , Male , Middle Aged , Esophageal Neoplasms/pathology , Esophageal Neoplasms/complications , Pericarditis/microbiology , Pericarditis/etiology , Pericarditis/therapy , Pericarditis/diagnosis , Carcinoma, Squamous Cell/pathology , Carcinoma, Squamous Cell/complications , Carcinoma, Squamous Cell/diagnosis , Esophageal Fistula/etiology , Esophageal Fistula/diagnosis , Streptococcal Infections/complications , Streptococcal Infections/diagnosis , Streptococcus anginosus/isolation & purification , Pericardiocentesis , Stents , Tomography, X-Ray Computed , Cardiac Tamponade/etiology
2.
J Clin Lab Anal ; 37(19-20): e24968, 2023 Oct.
Article in English | MEDLINE | ID: mdl-37803881

ABSTRACT

BACKGROUND: Candida pericardial infection is a rare clinical entity usually related to recent cardiothoracic surgery and chronic debilitating conditions. During the COVID-19 pandemic, invasive fungal infections have been on the rise, likely due to a combination of factors such as immunosuppression, underlying conditions like diabetes, and surgical procedures. CASE PRESENTATION: Herein, we report a 67-year-old diabetic woman with a history of COVID-19 infection who received a high dose of corticosteroids a few months before admission, and previous myocardial infarction for more than 12 years. The patient had a positive cardiac tamponade with signs of dyspnea, chest pain, and low blood pressure. Echocardiographic data were more in favor of constrictive pericarditis. The patient underwent urgent echocardiography-guided pericardiocentesis and then broad-spectrum antibiotic treatment was prescribed. Repeated echocardiography implied a persistent pericardial effusion 10 days later. Subxiphoid aspirates and biopsied tissues showed budding yeast cells and yeast colonies grew on culture media identified as Candida albicans. CONCLUSION: This report should bring to the attention of physicians toward the possibility of Candida pericardial infection presenting with cardiac tamponade after COVID-19 infection and cardiothoracic surgery. Echocardiographic assessment, prompt pericardiotomy, molecular-based identification of causative agent, and early administration of appropriate antifungal treatment should improve the patient's survival.


Subject(s)
COVID-19 , Candidiasis , Cardiac Tamponade , Pericarditis , Female , Humans , Aged , Cardiac Tamponade/etiology , Cardiac Tamponade/diagnosis , Cardiac Tamponade/surgery , Candida albicans , Pandemics , COVID-19/complications , Candidiasis/complications , Pericarditis/complications , Pericarditis/diagnosis , Pericarditis/microbiology
3.
J Infect Dev Ctries ; 16(9): 1517-1523, 2022 09 30.
Article in English | MEDLINE | ID: mdl-36223630

ABSTRACT

INTRODUCTION: Sepsis is a serious problem in felines with a mortality rate ranging from 29-79%. Neisseria spp. is considered a commensal microorganism of the oral cavity of dogs and cats and is usually isolated from human wounds resulting from bites of these animals. CASE REPORT: The present report describes clinical, imaging and laboratory findings of a feline with sepsis wherein commensal and multidrug-resistant (MDR) Neisseria spp. was isolated. The feline presented a history of four days of anorexia, dyspnea, prostration, and, pericardial, pleural and abdominal effusions. Pericardiocentesis was performed and hemorrhagic exudate was observed. The animal died after 11 days of treatment with gentamicin and amoxicillin combined with clavulanic acid. During necropsy, the abdominal cavity was found to be filled with greenish-yellow content and the pericardial sac was thickened with a large amount of purulent secretion. Histopathology revealed sepsis with necrotizing suppurative pericarditis, diffuse mononuclear pneumonia and necrotic pleuritis, leading to secondary bacterial infection. CONCLUSIONS: Commensal Neisseria spp. are important zoonotic bacteria, which trigger a serious disease in felines. However, it has not been reported to cause sepsis with pneumonia, suppurative necrotizing pericarditis and pericardial effusion.


Subject(s)
Cat Diseases , Dog Diseases , Pericarditis , Pneumonia , Sepsis , Amoxicillin , Animals , Cat Diseases/drug therapy , Cats , Clavulanic Acid , Dogs , Gentamicins , Humans , Neisseria , Pericarditis/microbiology , Pericarditis/therapy , Pneumonia/complications , Sepsis/drug therapy , Sepsis/veterinary
4.
BMC Pulm Med ; 21(1): 380, 2021 Nov 22.
Article in English | MEDLINE | ID: mdl-34809625

ABSTRACT

BACKGROUND: Chlamydia pneumoniae is a common cause of atypical community acquired pneumonia (CAP). The diagnostic approach of chlamydial infections remains a challenge. Diagnosis of delayed chlamydial-associated complications, involving complex autoimmune pathophysiological mechanisms, is still more challenging. C. pneumoniae-related cardiac complications have been rarely reported, including cases of endocarditis, myocarditis and pericarditis. CASE PRESENTATION: A 40-year old female was hospitalized for pleuropericarditis following lower respiratory tract infection. The patient had been hospitalized for CAP (fever, dyspnea, chest X-ray positive for consolidation on the left upper lobe) 5 weeks ago and had received ceftriaxone and moxifloxacin. Four weeks after her discharge, the patient presented with fever, shortness of breath and pleuritic chest pain and was readmitted because of pericardial and bilateral pleural effusions (mainly left). The patient did not improve on antibiotics and sequential introduction of colchicine and methylprednisolone was performed. The patient presented impressive clinical and laboratory response. Several laboratory and clinical assessments failed to demonstrate any etiological factor for serositis. Chlamydial IgM and IgG antibodies were positive and serial measurements showed increasing kinetics for IgG. Gold standard polymerase chain reaction of respiratory tract samples was not feasible but possibly would not have provided any additional information since CAP occurred 5 weeks ago. The patient was discharged under colchicine and tapered methylprednisolone course. During regular clinic visits, she remained in good clinical condition without pericardial and pleural effusions relapse. CONCLUSIONS: C. pneumoniae should be considered as possible pathogen in case of pleuritis and/or pericarditis during or after a lower respiratory tract infection. In a systematic review of the literature only five cases of C. pneumoniae associated pericarditis were identified. Exact mechanisms of cardiovascular damage have not yet been defined, yet autoimmune pathways might be implicated.


Subject(s)
Chlamydophila Infections/diagnosis , Chlamydophila pneumoniae/isolation & purification , Pericarditis/microbiology , Adult , Chlamydophila Infections/complications , Female , Humans , Pericarditis/diagnosis
5.
Can J Cardiol ; 37(10): 1629-1634, 2021 10.
Article in English | MEDLINE | ID: mdl-34375696

ABSTRACT

The mRNA vaccines against COVID-19 infection have been effective in reducing the number of symptomatic cases worldwide. With widespread uptake, case series of vaccine-related myocarditis/pericarditis have been reported, particularly in adolescents and young adults. Men tend to be affected with greater frequency, and symptom onset is usually within 1 week after vaccination. Clinical course appears to be mild in most cases. On the basis of the available evidence, we highlight a clinical framework to guide providers on how to assess, investigate, diagnose, and report suspected and confirmed cases. In any patient with highly suggestive symptoms temporally related to COVID-19 mRNA vaccination, standardized workup includes serum troponin measurement and polymerase chain reaction testing for COVID-19 infection, routine additional lab work, and a 12-lead electrocardiogram. Echocardiography is recommended as the imaging modality of choice for patients with unexplained troponin elevation and/or pathologic electrocardiogram changes. Cardiovascular specialist consultation and hospitalization should be considered on the basis of the results of standard investigations. Treatment is largely supportive, and myocarditis/pericarditis that is diagnosed according to defined clinical criteria should be reported to public health authorities in every jurisdiction. Finally, we recommend COVID-19 vaccination in all individuals in accordance with the Health Canada and National Advisory Committee on Immunization guidelines. In patients with suspected myocarditis/pericarditis after the first dose of an mRNA vaccine, deferral of a second dose is recommended until additional reports become available.


Subject(s)
COVID-19 Vaccines , COVID-19 , Myocarditis , Pericarditis , Risk Management , mRNA Vaccines , COVID-19/epidemiology , COVID-19/prevention & control , COVID-19 Testing/methods , COVID-19 Vaccines/administration & dosage , COVID-19 Vaccines/adverse effects , Canada/epidemiology , Diagnosis, Differential , Disease Notification/methods , Female , Humans , Male , Myocarditis/diagnosis , Myocarditis/etiology , Myocarditis/microbiology , Pericarditis/diagnosis , Pericarditis/etiology , Pericarditis/microbiology , Risk Management/methods , Risk Management/organization & administration , SARS-CoV-2/isolation & purification , Sex Factors , Young Adult , mRNA Vaccines/administration & dosage , mRNA Vaccines/adverse effects
6.
Chest ; 159(6): e403-e407, 2021 06.
Article in English | MEDLINE | ID: mdl-34099158

ABSTRACT

CASE PRESENTATION: A 70-year-old man presented to the ED with sudden onset of left thigh pain followed by transient chest discomfort. His history included cerebrovascular disease, hypertension, and cocaine and methamphetamine use. Physical examination revealed an uncomfortable male subject with a temperature of 37 °C, heart rate of 129 beats/min, BP of 130/65 mm Hg, and 98% oxygen saturation on room air. There was point tenderness in the left lateral thigh without erythema, swelling, or overlying skin changes. His cardiac examination revealed an irregular tachycardia at 129 beats/min and normal first and second heart sounds without murmurs, gallops, or rubs. The remainder of the examination was unremarkable.


Subject(s)
Pericardial Effusion , Pericarditis , Streptococcal Infections , Streptococcus pyogenes/isolation & purification , Aged , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/classification , Autopsy , Chest Pain/diagnosis , Chest Pain/etiology , Clinical Deterioration , Diagnosis, Differential , Echocardiography/methods , Electrocardiography/methods , Fatal Outcome , Humans , Male , Pericardial Effusion/diagnosis , Pericardial Effusion/etiology , Pericardial Effusion/physiopathology , Pericarditis/diagnosis , Pericarditis/microbiology , Pericarditis/physiopathology , Pericarditis/therapy , Streptococcal Infections/blood , Streptococcal Infections/physiopathology , Streptococcal Infections/therapy , Suppuration , Thigh/pathology , Thigh/physiopathology , Tomography, X-Ray Computed/methods
7.
Anaerobe ; 70: 102365, 2021 Aug.
Article in English | MEDLINE | ID: mdl-33887458

ABSTRACT

Bacterial pericarditis and empyema due to Cutibacterium acnes has rarely been reported. C.acnes, a normal component of human skin flora, is often considered a contaminant when isolated from body fluids and thus cases may be underreported. We report the first case of concurrent purulent pericarditis and empyema caused by C. acnes in a patient with newly diagnosed metastatic lung cancer. Our patient underwent pericardial window creation and placement of pericardial and bilateral chest tubes and was successfully treated with culture directed antibiotic therapy.


Subject(s)
Empyema/microbiology , Lung Neoplasms/complications , Pericarditis/microbiology , Adult , Anti-Bacterial Agents/administration & dosage , Empyema/drug therapy , Empyema/etiology , Female , Humans , Pericarditis/etiology , Propionibacteriaceae/drug effects , Propionibacteriaceae/genetics , Propionibacteriaceae/isolation & purification , Propionibacteriaceae/physiology
8.
Anaerobe ; 69: 102359, 2021 Jun.
Article in English | MEDLINE | ID: mdl-33771686

ABSTRACT

Cutibacterium acnes is an anaerobic bacterium commonly thought of as a culture contaminant rather than a pathogen. We present a case of Cutibacterium acnes pericarditis in a 22-year-old immunocompetent woman managed with surgical pericardial window and a 4-week course of penicillin G and review related literature on Cutibacterium acnes pericarditis.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Gram-Positive Bacterial Infections/complications , Penicillin G/therapeutic use , Pericarditis/drug therapy , Pericarditis/etiology , Pericarditis/surgery , Propionibacterium acnes/isolation & purification , Adult , Female , Gram-Positive Bacterial Infections/drug therapy , Humans , Immunocompromised Host , Pericarditis/microbiology , Treatment Outcome , Young Adult
9.
Am J Emerg Med ; 46: 801.e1-801.e3, 2021 08.
Article in English | MEDLINE | ID: mdl-33608167

ABSTRACT

Gastropericardial fistula is a rare but lethal condition. Several etiologies have been reported, including previous gastric or esophageal surgery, malignancy, trauma, infection, and ulcer perforation. Typical symptoms included chest pain, epigastric pain, fever and dyspnea. Gastropericardial fistula can lead to serious complications, including cardiac tamponade, sepsis, hemodynamic compromise and death. Therefore, early diagnosis and timely management are important for physicians to prevent from catastrophic complications. Here, we present a case of a man who presented with acute purulent pericarditis secondary to a gastropericardial fistula to highlight the pathogenesis and suggest therapeutic strategies.


Subject(s)
Fistula/complications , Gastric Fistula/complications , Pericarditis/etiology , Pericardium , Electrocardiography , Fatal Outcome , Humans , Male , Middle Aged , Pericardial Effusion/etiology , Pericardial Effusion/microbiology , Pericarditis/diagnosis , Pericarditis/diagnostic imaging , Pericarditis/microbiology , Radiography, Thoracic , Tomography, X-Ray Computed
10.
Ann Thorac Surg ; 111(4): e259-e261, 2021 04.
Article in English | MEDLINE | ID: mdl-32882194

ABSTRACT

The bacterial purulent pericarditis is rapidly progressive and represents a highly fatal infection, with mortality rates reaching up to 100% if untreated. Approximately 40% to 50% of all cases are caused by Gram-positive bacteria, especially Streptococcus pneumoniae. We describe an extremely rare case of S. pneumoniae purulent pericarditis as a delayed complication of a blunt thoracic trauma. The patient was successfully treated with urgent pericardiocentesis, thoracoscopic pericardial fenestration, and broad-spectrum antibiotics. Owing to the high mortality rate of a purulent pericarditis, a high index of suspicion is needed in order to instaurate an appropriate therapy with drainage and antibiotics.


Subject(s)
Pericarditis/etiology , Pericardium/diagnostic imaging , Pneumococcal Infections/etiology , Thoracic Injuries/complications , Wounds, Nonpenetrating/complications , Aged, 80 and over , Echocardiography , Female , Humans , Pericarditis/diagnosis , Pericarditis/microbiology , Pericardium/microbiology , Pneumococcal Infections/diagnosis , Pneumococcal Infections/microbiology , Radiography, Thoracic , Rare Diseases , Streptococcus pneumoniae/isolation & purification , Thoracic Injuries/diagnosis , Tomography, X-Ray Computed , Wounds, Nonpenetrating/diagnosis
11.
BMJ Case Rep ; 13(8)2020 Aug 25.
Article in English | MEDLINE | ID: mdl-32843461

ABSTRACT

Purulent pericarditis caused by Streptococcus anginosus is extremely rare. A 66-year-old man underwent elective coronary artery bypass surgery. This was complicated by sternal wound dehiscence with drainage. Subsequently, he developed fever, progressive dyspnoea and presyncope. Echocardiography showed a large pericardial effusion with evidence of tamponade. He underwent emergent pericardiocentesis. The pericardial fluid culture grew S. anginosus He was treated with 4 weeks of intravenous ceftriaxone with complete clinical recovery. The source of infection was most likely the sternal wound which was overlooked during debridement and rewiring surgery.


Subject(s)
Cardiac Tamponade/microbiology , Coronary Artery Bypass , Pericarditis/microbiology , Postoperative Complications/microbiology , Streptococcal Infections/complications , Streptococcus anginosus , Aged , Humans , Male , Suppuration/microbiology
12.
BMC Cardiovasc Disord ; 20(1): 392, 2020 08 27.
Article in English | MEDLINE | ID: mdl-32854624

ABSTRACT

BACKGROUND: Pericardial constriction is one of the complications of purulent pericarditis (PP). Most difficult to treat, which may develop both in early and in the late period of the disease, resulting in a very poor prognosis. CASE PRESENTATION: We present case series of 4 patients with purulent pericarditis, in whom direct intrapericardial administration of recombinant tissue plasminogen activator (r-tPA) was used. Management of PP requires a combined surgical and medical approach. The most important is complete drainage of the effusion by subxiphoid pericardiotomy connected with complementary use of broad-spectrum antibiotics. Despite the use of broad- spectrum antibiotics, in some patients a large volume of daily drainage is still present. Constrictive pericarditis as a complication of PP is observed in majority of patients. Intrapericardial administration of fibrinolytic agents, although not strongly recommended, can improve efficacy of antibiotic treatment especially in patients with loculation fluid and can prevent the development of constrictive pericarditis. r-tPA was applied at a dose of 20 mg dissolved in 100 ml of normal saline in a 100 ml syringe, administered by a large pericardial drain (Pezzer drain) installed into the pericardial cavity during pericardioscopy. The tube was closed and re-opened after 24 h. No serious complications, such as bleeding, allergy or hypotension, were noted. CONCLUSION: We present case series of 4 patients with purulent pericarditis, in whom direct intrapericardial administration of recombinant tissue plasminogen activator (r-tPA), prevented the development of constrictive pericarditis, and increased efficacy of antibiotic treatment without any significant complications.


Subject(s)
Fibrinolytic Agents/administration & dosage , Pericarditis, Constrictive/prevention & control , Pericarditis/drug therapy , Tissue Plasminogen Activator/administration & dosage , Adult , Aged , Anti-Bacterial Agents/therapeutic use , Female , Humans , Male , Middle Aged , Pericardiectomy , Pericarditis/diagnostic imaging , Pericarditis/microbiology , Pericarditis, Constrictive/diagnostic imaging , Pericarditis, Constrictive/microbiology , Recombinant Proteins/administration & dosage , Treatment Outcome
13.
Transpl Infect Dis ; 22(6): e13366, 2020 Dec.
Article in English | MEDLINE | ID: mdl-32533755

ABSTRACT

We present a case of Cryptococcus neoformans pericarditis in a cardiac transplant recipient. This article reviews the diagnosis, treatment, and complications of cryptococcosis specifically in transplant patients. While pericarditis is a rare manifestation of Cryptococcus infection, this case highlights that cryptococcosis should be considered in the differential diagnosis for solid organ transplant and immunocompromised patients presenting with pericardial effusions.


Subject(s)
Cryptococcosis/diagnosis , Cryptococcus neoformans/isolation & purification , Heart Transplantation/adverse effects , Pericarditis/diagnosis , Adult , Aged , Antifungal Agents/therapeutic use , Cryptococcosis/microbiology , Cryptococcosis/therapy , Echocardiography/methods , Female , Fluconazole/therapeutic use , Humans , Immunocompromised Host , Male , Middle Aged , Organ Transplantation/adverse effects , Pericardiocentesis/methods , Pericarditis/microbiology , Pericarditis/therapy , Treatment Outcome
15.
BMC Cardiovasc Disord ; 20(1): 28, 2020 03 24.
Article in English | MEDLINE | ID: mdl-32209051

ABSTRACT

BACKGROUND: In the workup of a pediatric patient with pericarditis we found evidence of a pseudo-aneurysm of the left ventricle, which is a rare complication of purulent pericarditis. CASE PRESENTATION: We present a case of a six-year-old girl who was diagnosed with pericarditis and a fistula between the pericardial and the intra-luminal space of the left ventricle of the heart. She was successfully treated with antibiotics and cardio-thoracic surgery. We found 23 published cases (21 with follow-up) of infectious pseudo-aneurysm of the heart, of which 19 underwent surgery, 5 had fatal outcome, and 2 who refused surgery survived. The majority of cases were associated with Staphylococcus aureus. The exact mechanisms of this rare complication remain unknown. CONCLUSIONS: A pseudo-aneurysm of the left ventricle is a rare and not well understood complication of a purulent pericarditis most commonly caused by Staphylococcus aureus infection. Because of risk of rupture, surgical intervention is advised.


Subject(s)
Aneurysm, False/microbiology , Aneurysm, Infected/microbiology , Heart Neoplasms/microbiology , Osteomyelitis/microbiology , Pericarditis/microbiology , Staphylococcal Infections/microbiology , Aneurysm, False/diagnostic imaging , Aneurysm, False/therapy , Aneurysm, Infected/diagnostic imaging , Aneurysm, Infected/therapy , Anti-Bacterial Agents/therapeutic use , Cardiac Surgical Procedures , Child , Female , Heart Neoplasms/diagnostic imaging , Heart Neoplasms/therapy , Humans , Osteomyelitis/complications , Osteomyelitis/diagnosis , Osteomyelitis/therapy , Pericarditis/diagnostic imaging , Pericarditis/therapy , Staphylococcal Infections/complications , Staphylococcal Infections/diagnosis , Staphylococcal Infections/therapy , Treatment Outcome
16.
Am J Case Rep ; 21: e921633, 2020 Feb 28.
Article in English | MEDLINE | ID: mdl-32107365

ABSTRACT

BACKGROUND Acute bacterial pericarditis is rare, and the incidence numbers have been declining in the modern antibiotic era. Purulent bacterial pericarditis is a fatal disease in which mortality rates can reach 100% if left untreated. CASE REPORT We present a case of primary purulent bacterial pericarditis with polymicrobial growth including Micromonas micro, Prevotella intermedia and Fusobacterium species, all of which are anaerobic flora of the oral cavity. Constant re-accumulation of the purulent pericardial effusion led the patient to have recurrent echocardiographic and clinical cardiac tamponade requiring recurrent pericardiocentesis' and eventually a pericardial window. CONCLUSIONS Although rare, bacterial pericarditis has been noted to lead to clinical and echocardiographic tamponade. Early diagnosis and treatment are necessary for improving clinical outcomes. It is important to have a suspicion for purulent pericarditis, due to its high level of mortality, in patients who present with non-specific symptoms and pleuritic chest pain.


Subject(s)
Bacteria, Anaerobic/drug effects , Cardiac Tamponade/microbiology , Cardiac Tamponade/therapy , Pericarditis/microbiology , Pericarditis/therapy , Adult , Anti-Bacterial Agents/therapeutic use , Fusobacterium/drug effects , Humans , Male , Pericardiocentesis , Prevotella intermedia/drug effects , Rare Diseases
18.
Paediatr Int Child Health ; 40(3): 207-210, 2020 08.
Article in English | MEDLINE | ID: mdl-32052706

ABSTRACT

CHLAMYDOPHILA PNEUMONIAE: , a common cause of respiratory tract infections, rarely leads to serious conditions. A 13-year-old boy with serologically confirmed C. pneumoniae infection presented with pneumonia complicated by pericardial and bilateral pleural effusions. He had a large haemorrhagic pericardial effusion from which 1000 ml of fluid was aspirated over 10 days and a right haemorrhagic pleural effusion which required a chest drain and the removal of 700 ml over 5 days. The addition of clarithromycin to ceftriaxone appeared to enhance recovery. As far as we are aware, this is the first report in the English literature of massive haemorrhagic pericardial and pleural effusions in children owing to C. pneumoniae infection.


Subject(s)
Ceftriaxone/therapeutic use , Chlamydial Pneumonia/complications , Chlamydial Pneumonia/microbiology , Clarithromycin/therapeutic use , Pericarditis/microbiology , Pericarditis/pathology , Adolescent , Ceftriaxone/administration & dosage , Chlamydophila pneumoniae/immunology , Chlamydophila pneumoniae/isolation & purification , Clarithromycin/administration & dosage , Humans , Immunoglobulin G/chemistry , Immunoglobulin G/metabolism , Immunoglobulin M/chemistry , Immunoglobulin M/metabolism , Male , Sputum/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...